Atlas Trials

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

Clinical trial NCT02692105 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT02692105
Sponsor
British Columbia Cancer Agency
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Prostate Cancer
Start date
2016-05-01
Primary completion
2021-04-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.